Literature DB >> 19457810

Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma.

Weining Ma1, Stella K Kang, Hedvig Hricak, Scott R Gerst, Jingbo Zhang.   

Abstract

OBJECTIVE: The purpose of our study is to present the radiographic findings in a series of 16 patients with complications associated with intravesical bacille Calmette-Guérin (BCG) treatment of bladder cancer.
CONCLUSION: Intravesical BCG-related complications such as granulomatous disease may show imaging findings mimicking primary or metastatic tumors in patients with bladder cancer. Radiologists should consider this possibility when imaging abnormalities are encountered in bladder cancer patients treated with intravesical BCG so that appropriate management can be administered and unnecessary procedures avoided.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457810     DOI: 10.2214/AJR.08.1962

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

1.  Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.

Authors:  Masashi Matsushima; Eiji Kikuchi; Hirotaka Akita; Akira Miyajima; Mototsugu Oya; Masahiro Jinzaki
Journal:  Int J Clin Oncol       Date:  2017-02-10       Impact factor: 3.402

2.  Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.

Authors:  Jennifer K Logan; Annerleim Walton-Diaz; Soroush Rais-Bahrami; Maria J Merino; Baris Turkbey; Peter L Choyke; Peter A Pinto
Journal:  J Comput Assist Tomogr       Date:  2014 Mar-Apr       Impact factor: 1.826

3.  Bacillus Calmette-Guérin therapy-associated granulomatous prostatitis mimicking prostate cancer on MRI: A case report and literature review.

Authors:  Nicolaie Suditu; Dragos Negru
Journal:  Mol Clin Oncol       Date:  2014-09-19

Review 4.  Urinary bladder: normal appearance and mimics of malignancy at CT urography.

Authors:  Atul B Shinagare; Cheryl A Sadow; V Anik Sahni; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2011-06-28       Impact factor: 3.909

5.  Multiparametric Magnetic Resonance Imaging Characteristics of Prostate Tuberculosis.

Authors:  Yue Cheng; Lixiang Huang; Xiaodong Zhang; Qian Ji; Wen Shen
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

6.  Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder.

Authors:  Suresh Bhat; Yateesh Srinivasa; Fredrick Paul
Journal:  Indian J Urol       Date:  2015 Jul-Sep

7.  Multiphase contrast-enhanced magnetic resonance imaging features of Bacillus Calmette-Guérin-induced granulomatous prostatitis in five patients.

Authors:  Hiroshi Kawada; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Haruo Watanabe; Yoshifumi Noda; Yukichi Tanahashi; Nobuyuki Kawai; Hiroaki Hoshi
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

Review 8.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

Authors:  Valeria Panebianco; Yoshifumi Narumi; Ersan Altun; Bernard H Bochner; Jason A Efstathiou; Shaista Hafeez; Robert Huddart; Steve Kennish; Seth Lerner; Rodolfo Montironi; Valdair F Muglia; Georg Salomon; Stephen Thomas; Hebert Alberto Vargas; J Alfred Witjes; Mitsuru Takeuchi; Jelle Barentsz; James W F Catto
Journal:  Eur Urol       Date:  2018-05-10       Impact factor: 20.096

Review 9.  Current concepts in granulomatous immune responses.

Authors:  Melinda Herbath; Zsuzsanna Fabry; Matyas Sandor
Journal:  Biol Futur       Date:  2021-02-25

10.  Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.

Authors:  Karen Tran-Harding; Rashmi T Nair; Halemane Ganesh
Journal:  J Clin Imaging Sci       Date:  2018-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.